1.	A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer Phase: Phase III, Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: EF024-201, NCT01249352
2.	Nimotuzumab in Adults With Glioblastoma Multiforma Phase: Phase III Type: Treatment Status: Closed Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: OSAG101-BSA05, NCT00753246
3.	Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Phase: Phase II Type: Treatment Status: Completed Age: 3 to 18 Sponsor: Pharmaceutical / Industry Protocol IDs: YMB1000-013, NCT00600054
4.	Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: HNTG 09-01, NCT00910117
5.	Phase I Study of Nimotuzumab in Solid Tumours Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: YMB1000-007, NCT00369252